North Star Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

North Star Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$746	Hold	60	–	–	﹤0.01%	1534
2025 Q4	$756	Hold	60	–	–	﹤0.01%	1420
2025 Q3	$601	Hold	60	–	–	﹤0.01%	1210
2025 Q2	$485	Hold	60	–	–	﹤0.01%	1160
2025 Q1	$503	Hold	60	–	–	﹤0.01%	1144
2024 Q4	$475	Hold	60	–	–	﹤0.01%	1172
2024 Q3	$499	Hold	60	–	–	﹤0.01%	1132
2024 Q2	$381	Hold	60	–	–	﹤0.01%	1114
2024 Q1	$364	Hold	60	–	–	﹤0.01%	1186
2023 Q4	$364	Hold	60	–	–	﹤0.01%	1148
2023 Q3	$253	Hold	60	–	–	﹤0.01%	1236
2023 Q2	$186	Hold	60	–	–	﹤0.01%	1253
2023 Q1	$83	Hold	60	–	–	﹤0.01%	1284
2022 Q4	$119	Hold	60	–	–	﹤0.01%	1289
2022 Q3	$0	Hold	60	–	–	﹤0.01%	1131
2022 Q2	$0	Hold	60	–	–	﹤0.01%	1131
2022 Q1	$0	Hold	60	–	–	﹤0.01%	1145
2021 Q4	$0	Sell	60 -300	-83%	-$1.5K	﹤0.01%	1173
2021 Q3	$2K	Buy	360 +300	+500%	+$1.51K	﹤0.01%	1022
2021 Q2	$0	Hold	60	–	–	﹤0.01%	1093
2021 Q1	$0	Hold	60	–	–	﹤0.01%	1053
2020 Q4	$0	Hold	60	–	–	﹤0.01%	1020
2020 Q3	$0	Hold	60	–	–	﹤0.01%	1000
2020 Q2	$0	Hold	60	–	–	﹤0.01%	971
2020 Q1	$0	Hold	60	–	–	﹤0.01%	995
2019 Q4	$0	Hold	60	–	–	﹤0.01%	1038
2019 Q3	$0	Buy	+60	New	+$209	﹤0.01%	1088

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

North Star Investment Management's AMRX Position: Q1 2026 in Review

North Star Investment Management held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 60 shares worth $746. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

North Star Investment Management first reported a position in AMRX in Q3 2019 and has held it in 27 quarters since. The position peaked at $2K in Q3 2021. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

North Star Investment Management held 60 shares of Amneal Pharmaceuticals worth $746 as of Q1 2026.
North Star Investment Management left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
Amneal Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1534 holding.
North Star Investment Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
North Star Investment Management's Amneal Pharmaceuticals position peaked at $2K in Q3 2021.
316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.